Pfizer, U.K. experts seek approval for stem cell clinical trial

10/9/2011 | Wall Street Journal, The

Pfizer and scientists at the University College London's Institute of Ophthalmology have asked U.K. regulators to allow them to start a clinical trial of retinal cells, derived from human embryonic stem cells, in patients with age-related macular degeneration. They hope to conduct the U.K. study in 2012.

View Full Article in:

Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT